INS and Hypoglycemia: The unadjusted incidence of treatment deintensification after a hypoglycemia-associated ED visit or hospitalization was highest among individuals receiving both sulfonylurea and insulin (6677 episodes [48.1%]), followed by those receiving sulfonylurea only (14 192 episodes [44.2%]) (Table 3).